Guggulipids, lipid-soluble bioactives derived from the resin of Commiphora mukul, have gained increasing scientific attention for their diverse pharmacological properties. This review provides a comprehensive synthesis of current findings on the bioactivity, therapeutic potential, and advanced delivery systems of guggulipids. Beginning with a brief overview of their traditional medicinal significance, we outline key mechanisms of action, including modulation of lipid metabolism, modulation of anti-inflammatory pathways, antioxidant activity, and regulation of apoptosis. We examine preclinical and clinical evidence supporting the use of guggulipids in managing cardiovascular diseases, metabolic syndromes, and chronic inflammatory conditions. Special attention is given to recent innovations in drug delivery strategies, such as nanoparticles, proniosomal gels, and guggulosomes, which are designed to overcome the challenges of poor solubility and limited bioavailability. Additionally, emerging research avenues are discussed, including synergistic interactions with other phytochemicals and personalized medicine approaches. By integrating traditional knowledge with modern pharmacological insights, this review aims to guide future research and therapeutic applications of guggulipids in evidence-based medicine.
Sharma et al. (Wed,) studied this question.